CELIXIR Trademark

Trademark Overview


On Thursday, January 12, 2017, a trademark application was filed for CELIXIR with the United States Patent and Trademark Office. The USPTO has given the CELIXIR trademark a serial number of 79205912. The federal status of this trademark filing is REGISTERED as of Tuesday, March 13, 2018. This trademark is owned by Cell Therapy Limited. The CELIXIR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem...
celixir

General Information


Serial Number79205912
Word MarkCELIXIR
Filing DateThursday, January 12, 2017
Status700 - REGISTERED
Status DateTuesday, March 13, 2018
Registration Number5420465
Registration DateTuesday, March 13, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of damaged skin, tissue, organs and body parts; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases; veterinary pharmaceutical preparations for the treatment of damaged or diseased skin, tissue, organs and body parts; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical and veterinary pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations and substances for the treatment of damaged skin and tissue, namely, tissue regenerative pharmaceutical preparations; cellular medicines, namely, stem cells for medical or veterinary use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 1, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCell Therapy Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameCell Therapy Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameCell Therapy Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Monday, March 13, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, December 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 25, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 20, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, June 21, 2018FINAL DISPOSITION NOTICE SENT TO IB
Thursday, June 21, 2018FINAL DISPOSITION PROCESSED
Wednesday, June 13, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 13, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Friday, December 22, 2017NOTIFICATION PROCESSED BY IB
Wednesday, December 6, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 6, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Thursday, November 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 14, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, November 14, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 14, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, November 14, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, August 17, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, August 17, 2017FINAL REFUSAL E-MAILED
Thursday, August 17, 2017FINAL REFUSAL WRITTEN
Friday, August 4, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 4, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 26, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 25, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 3, 2017REFUSAL PROCESSED BY IB
Tuesday, May 16, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 16, 2017REFUSAL PROCESSED BY MPU
Tuesday, May 9, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 8, 2017NON-FINAL ACTION WRITTEN
Friday, May 5, 2017APPLICATION FILING RECEIPT MAILED
Monday, May 1, 2017ASSIGNED TO EXAMINER
Monday, May 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 27, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB